A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112
NCT03116113
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
X-Linked Retinitis Pigmentosa
Interventions
BIOLOGICAL:
BIIB112
Sponsor
Biogen